Total planned funding: $121,500,000

Allocations

$121,500,000

Private Contractor	$41,845,920
NGO	$40,635,799
Own Agency	$17,846,696
Implementing Agency	$10,893,988
Unknown	$8,726,297
University	$1,001,300
Host Country Government Agency	$500,000
Other USG Agency	$50,000

HTXD: Treatment: ARV Drugs	$26,030,711
HTXS: Treatment: Adult Treatment	$17,826,642
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision	$16,938,414
HKID: Care: Orphans and Vulnerable Children	$9,961,819
HVMS: Management and Operations	$9,806,930
OHSS: Health Systems Strengthening	$6,816,689
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission	$6,693,685
HVCT: Testing: HIV Testing and Counseling	$5,537,882
PDTX: Treatment: Pediatric Treatment	$4,014,246
HVTB: Care: TB/HIV	$3,364,303
HVOP: Sexual Prevention: Other Sexual Prevention	$2,936,425
HVSI: Strategic Information	$2,764,809
PDCS: Care: Pediatric Care and Support	$2,720,873
HBHC: Care: Adult Care and Support	$2,595,759
HLAB: Laboratory Infrastructure	$2,155,539
HVAB: Sexual Prevention: Abstinence/Be Faithful	$1,335,274
HMBL: Biomedical Prevention: Blood Safety	$0
HMIN: Biomedical Prevention: Injection Safety	$0